| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 477,2 k € | -11.2% | 537,1 k € | +44.1% | 372,8 k € | -20.2% | 467,0 k € | -10.8% | 523,6 k € | +24.2% | 421,5 k € | -13.2% | 485,4 k € | +33.2% | 364,5 k € | +5.4% | 346,0 k € | -16.3% | 413,1 k € | -12.2% | 470,4 k € | +15.2% | 408,5 k € | -15.5% | 483,1 k € | +58.6% | 304,7 k € | -18.3% | 372,7 k € | -53.0% | 793,0 k € | +17.4% | 675,7 k € | +3.8% | 651,1 k € | +17.8% | 552,8 k € | -3.3% | 571,4 k € | |
| EBITDA | 469,6 k € | -11.1% | 528,4 k € | +46.2% | 361,5 k € | -20.9% | 456,8 k € | -10.6% | 510,7 k € | +23.3% | 414,2 k € | -13.4% | 478,4 k € | +33.2% | 359,1 k € | +5.8% | 339,5 k € | -16.2% | 404,9 k € | +9.2% | 370,8 k € | -8.0% | 402,8 k € | -15.8% | 478,3 k € | +59.1% | 300,7 k € | -18.4% | 368,3 k € | -53.1% | 784,9 k € | +16.5% | 673,9 k € | +3.9% | 648,8 k € | +17.7% | 551,1 k € | -3.3% | 569,9 k € | |
| Operating profit | 434,8 k € | -11.5% | 491,2 k € | +74.1% | 282,1 k € | -23.4% | 368,2 k € | -15.1% | 433,6 k € | +29.7% | 334,4 k € | -15.8% | 397,0 k € | +48.6% | 267,3 k € | +6.8% | 250,4 k € | -21.1% | 317,1 k € | +16.9% | 271,3 k € | -19.7% | 337,6 k € | -19.3% | 418,3 k € | +76.0% | 237,6 k € | -23.1% | 308,8 k € | -57.4% | 724,3 k € | +29.0% | 561,7 k € | -10.6% | 628,0 k € | +17.7% | 533,4 k € | -3.2% | 550,9 k € | |
| Profit/loss | 348,9 k € | -18.0% | 425,7 k € | +126.2% | 188,2 k € | -30.8% | 272,2 k € | -8.9% | 298,8 k € | +30.3% | 229,3 k € | -11.4% | 258,9 k € | +51.3% | 171,0 k € | +19.2% | 143,5 k € | -26.0% | 193,9 k € | +68.8% | 114,9 k € | -52.4% | 241,3 k € | -14.5% | 282,3 k € | +79.0% | 157,7 k € | -24.0% | 207,5 k € | -56.2% | 474,2 k € | +28.7% | 368,4 k € | -13.3% | 424,7 k € | +20.7% | 351,9 k € | -3.0% | 362,8 k € | |
| Equity | 2,3 M € | -3.1% | 2,3 M € | +22.3% | 1,9 M € | +2.5% | 1,9 M € | +10.3% | 1,7 M € | -8.8% | 1,8 M € | +3.5% | 1,8 M € | +16.9% | 1,5 M € | +12.5% | 1,4 M € | +11.8% | 1,2 M € | +19.1% | 1,0 M € | +12.7% | 902,7 k € | +36.5% | 661,3 k € | +74.5% | 379,0 k € | +71.3% | 221,3 k € | -54.1% | 482,6 k € | +5636.4% | 8,4 k € | -15.9% | 10,0 k € | -97.2% | 360,3 k € | +4178.6% | 8,4 k € | |
| Total assets | 2,3 M € | -8.5% | 2,5 M € | +22.7% | 2,0 M € | -0.5% | 2,0 M € | +10.7% | 1,8 M € | -7.2% | 2,0 M € | -0.9% | 2,0 M € | +10.0% | 1,8 M € | +5.0% | 1,7 M € | +2.4% | 1,7 M € | +11.0% | 1,5 M € | +35.4% | 1,1 M € | +18.7% | 947,6 k € | +45.7% | 650,3 k € | -9.2% | 716,3 k € | -17.3% | 865,9 k € | +4.0% | 832,5 k € | -2.6% | 855,1 k € | +118.7% | 391,0 k € | -2.8% | 402,2 k € | |
| Cash | 426,2 k € | -21.5% | 543,2 k € | -10.5% | 607,1 k € | -3.4% | 628,6 k € | +42.6% | 440,7 k € | -32.5% | 652,5 k € | -5.7% | 691,8 k € | +51.8% | 455,8 k € | +1.4% | 449,7 k € | -10.6% | 503,1 k € | -12.4% | 574,5 k € | -11.2% | 646,8 k € | +59.8% | 404,7 k € | +407.4% | 79,8 k € | -50.7% | 161,9 k € | -20.8% | 204,3 k € | +6.6% | 191,6 k € | -72.3% | 692,2 k € | +170.5% | 255,9 k € | -1.4% | 259,6 k € | |
| Debts | 19,8 k € | -87.5% | 159,0 k € | +29.0% | 123,3 k € | -31.5% | 179,9 k € | +14.5% | 157,1 k € | +17.2% | 134,1 k € | -34.7% | 205,3 k € | -26.7% | 280,1 k € | -22.6% | 361,7 k € | -20.9% | 457,4 k € | -7.3% | 493,3 k € | +121.7% | 222,5 k € | -22.1% | 285,7 k € | +5.3% | 271,3 k € | -45.1% | 494,2 k € | +29.3% | 382,3 k € | -53.6% | 823,5 k € | -2.6% | 845,1 k € | +2654.5% | 30,7 k € | -92.2% | 392,1 k € | |
Private limited company · Zemst · incorporated on 01/02/2000
Private limited company profitable and well capitalised. Cash position declining (-21.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DOKTERS D'HAENS EN DRIJVERS is a Private limited company incorporated in 2000. Its main activity is: Autres activités pour la santé humaine n.c.a.. Its registered office is in Zemst.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette